These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24365051)

  • 1. Multicomponent nanochains for treating cancer micrometastasis.
    Park K
    J Control Release; 2014 Jan; 173():166. PubMed ID: 24365051
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle.
    Peiris PM; Toy R; Abramowski A; Vicente P; Tucci S; Bauer L; Mayer A; Tam M; Doolittle E; Pansky J; Tran E; Lin D; Schiemann WP; Ghaghada KB; Griswold MA; Karathanasis E
    J Control Release; 2014 Jan; 173():51-8. PubMed ID: 24188960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle delivery for metastatic breast cancer.
    Grobmyer SR; Zhou G; Gutwein LG; Iwakuma N; Sharma P; Hochwald SN
    Nanomedicine; 2012 Sep; 8 Suppl 1():S21-30. PubMed ID: 22640908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery approaches for breast cancer.
    Singh SK; Singh S; Lillard JW; Singh R
    Int J Nanomedicine; 2017; 12():6205-6218. PubMed ID: 28883730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermo-responsive fibrinogen nanogels: a viable thermo-responsive drug delivery agent for breast cancer therapy?
    Sreerenganathan M; Mony U; Rangasamy J
    Nanomedicine (Lond); 2014 Dec; 9(18):2721-3. PubMed ID: 25535683
    [No Abstract]   [Full Text] [Related]  

  • 6. Accelerating the multifunctionalization of therapeutic nanoparticles by using a multicomponent reaction.
    Zhou H; Su G; Jiao P; Yan B
    Chemistry; 2012 Apr; 18(18):5501-5. PubMed ID: 22437991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual nanoparticle drug delivery: the future of anticancer therapies?
    King MR; Mohamed ZJ
    Nanomedicine (Lond); 2017 Jan; 12(2):95-98. PubMed ID: 27885896
    [No Abstract]   [Full Text] [Related]  

  • 8. San Antonio Breast Cancer Symposium--27th Annual Meeting.
    Susman E
    IDrugs; 2005 Jan; 8(1):21-4. PubMed ID: 15650936
    [No Abstract]   [Full Text] [Related]  

  • 9. Mesoporous silica nanoparticles: a smart nanosystem for management of breast cancer.
    Poonia N; Lather V; Pandita D
    Drug Discov Today; 2018 Feb; 23(2):315-332. PubMed ID: 29128658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer.
    Yuan Y; Cai T; Xia X; Zhang R; Chiba P; Cai Y
    Drug Deliv; 2016 Nov; 23(9):3350-3357. PubMed ID: 27098896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.
    Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J
    Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetically targeted nanoparticles for brain tumor therapy: what does the future hold?
    David AE; Cole AJ; Yang VC
    Nanomedicine (Lond); 2011 Sep; 6(7):1133-5. PubMed ID: 21929450
    [No Abstract]   [Full Text] [Related]  

  • 13. Nanoparticles: the future for platinum drugs or a research red herring?
    Wheate NJ
    Nanomedicine (Lond); 2012 Sep; 7(9):1285-7. PubMed ID: 22994954
    [No Abstract]   [Full Text] [Related]  

  • 14. Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancer.
    Wang B; Rosano JM; Cheheltani R; Achary MP; Kiani MF
    Expert Opin Drug Deliv; 2010 Oct; 7(10):1159-73. PubMed ID: 20738211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic nanoparticle holds promise in blocking aggressive breast cancer.
    Printz C
    Cancer; 2010 Dec; 116(24):5567. PubMed ID: 21218458
    [No Abstract]   [Full Text] [Related]  

  • 16. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
    Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
    J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cover Story: Nanoparticle properties affecting nuclear targeting in cancer and normal cells.
    Park K
    J Control Release; 2017 May; 253():184. PubMed ID: 28601163
    [No Abstract]   [Full Text] [Related]  

  • 18. Promising approaches in using magnetic nanoparticles in oncology.
    Mikhaylov G; Vasiljeva O
    Biol Chem; 2011 Nov; 392(11):955-60. PubMed ID: 21848508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New strategies in melanoma therapy: can nanoparticles overcome chemoresistance?
    Badea I
    Nanomedicine (Lond); 2017 Jul; 12(14):1623-1626. PubMed ID: 28635551
    [No Abstract]   [Full Text] [Related]  

  • 20. Second-line treatment of postmenopausal women with advanced breast carcinoma.
    Board RE; Dean EJ; Mitchell C; Wardley AM
    Expert Rev Anticancer Ther; 2006 Apr; 6(4):613-24. PubMed ID: 16613548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.